Explore more publications!

Kingstown Political Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kingstown Political Times.

Press releases published on February 9, 2026

Portnoy Law Firm Announces Class Action on Behalf of Ardent Health, Inc.. Investors
Portnoy Law Firm Announces Class Action on Behalf of Coupang, Inc. Investors
Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors
Portnoy Law Firm Announces Class Action on Behalf of Fermi, Inc. Investors
Pace Center for Girls Announces Rebecca Ndombi as Chief Advancement Officer
ATTENTION NASDAQ: MREO INVESTORS: Contact Berger Montague About a Mereo BioPharma Group PLC Class Action Lawsuit
The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)
AMPLIFY Tracks Supreme Court Cruise Case With Major Implications for Cruise-Ship Injury and Maritime Liability
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
CRWV SECURITIES NOTICE: Did CoreWeave, Inc. Mislead Investors about its Infrastructure Delays? Contact BFA Law about the Pending Securities Fraud Class Action
BRBR SECURITIES NOTICE: Did BellRing Brands, Inc. Mislead Investors about its Inventory Levels? Contact BFA Law about the Pending Securities Fraud Class Action
HUBG SECURITIES NOTICE: Did Hub Group Inc. Mislead Investors about its Accounting? Contact BFA Law about its Pending Securities Investigation
PLUG SECURITIES NOTICE: Did Plug Power Inc. Mislead Investors about its DOE Funding? Contact BFA Law about the Pending Securities Fraud Class Action
PFSI SECURITIES NOTICE: Did PennyMac Financial Services, Inc. Mislead Investors about its Refinancing Issues? Contact BFA Law about its Pending Securities Investigation
WLTH SECURITIES NOTICE: Did Wealthfront Corporation Mislead Investors about its Home-Lending Business? Contact BFA Law about its Pending Securities Investigation
ARDT SECURITIES NOTICE: Did Ardent Health, Inc. Mislead Investors about its Collectability Issues? Contact BFA Law about its Pending Securities Fraud Class Action
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions